Work

NEJM at ESMO — Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma

Year: 2024

Type: article

Source: New England Journal of Medicine

DOI: 10.1056/nejme2411494

Authors: Eric J. Rubin, Oladapo O. Yeku, Stephen Morrissey

Language: English

Topic: Gastric Cancer Management and Outcomes

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4402581831

FWCI: 0.581

Cites:

Cited by: 2

Related to: 10